EP 1144654 A2 20011017 - SERINE PROTEASE
Title (en)
SERINE PROTEASE
Title (de)
SERINPROTEASE
Title (fr)
NOUVEAU COMPOSE
Publication
Application
Priority
- GB 0003680 W 20000925
- GB 9922835 A 19990925
Abstract (en)
[origin: WO0123587A2] HETAA37 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HETAA37 polypeptides and polynucleotides in the design of protocols for the treatment of cancer, inflammation, asthma, wasting diseases, atherosclerosis, stroke, diabetes, arthritis, Alzheimer's and other neurodegenerative diseases, and other neurological disorders, among others, and diagnostic assays for such conditions.
IPC 1-7
C12N 15/57; C12N 9/64; C12N 5/10; C12N 15/63; C12P 21/02; C07K 16/40; A61K 38/43; C12Q 1/68; G01N 33/573
IPC 8 full level
C12N 9/64 (2006.01); C12N 15/57 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP)
C12N 9/6424 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 48/00 (2013.01)
Designated contracting state (EPC)
GB
DOCDB simple family (publication)
WO 0123587 A2 20010405; WO 0123587 A3 20011011; EP 1144654 A2 20011017; EP 1144654 A3 20020227; GB 9922835 D0 19991124
DOCDB simple family (application)
GB 0003680 W 20000925; EP 00962730 A 20000925; GB 9922835 A 19990925